NanoViricides
NNVC
#10397
Rank
โ‚ฌ26.71 M
Marketcap
1,16ย โ‚ฌ
Share price
-1.48%
Change (1 day)
-0.77%
Change (1 year)

Market capitalization of NanoViricides (NNVC)

Market cap: โ‚ฌ26.71 Million

As of July 2026 NanoViricides has a market cap of โ‚ฌ26.71 Million. This makes NanoViricides the world's 10397th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of NanoViricides from 2007 to 2026

End of year Market Cap

Year Marketcap Change
2026โ‚ฌ26.71 M22.29%
2025โ‚ฌ21.84 M5.65%
2024โ‚ฌ20.68 M90.82%
2023โ‚ฌ10.83 M-9.79%
2022โ‚ฌ12.01 M-68.26%
2021โ‚ฌ37.85 M52.13%
2020โ‚ฌ24.88 M186.95%
2019โ‚ฌ8.67 M-28.63%
2018โ‚ฌ12.15 M-73.85%
2017โ‚ฌ46.45 M-21.54%
2016โ‚ฌ59.2 M-5.12%
2015โ‚ฌ62.4 M-50.67%
2014โ‚ฌ0.12 B-27.27%
2013โ‚ฌ0.17 B207.49%
2012โ‚ฌ56.56 M-19.36%
2011โ‚ฌ70.15 M-54.27%
2010โ‚ฌ0.15 B96%
2009โ‚ฌ78.26 M10.08%
2008โ‚ฌ71.09 M123.39%
2007โ‚ฌ31.82 M

End of Day market cap according to different sources

On Jul 3rd, 2026 the market cap of NanoViricides was reported to be:

โ‚ฌ26.71 Million
by Nasdaq info icon info icon
โ‚ฌ26.71 Million
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Gilead Sciences
GILD
โ‚ฌ142.46 B 533,089.75%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
โ‚ฌ279.70 B 1,046,744.43%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚ฌ103.76 B 388,243.75%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
โ‚ฌ93.93 B 351,487.05%๐Ÿ‡ฌ๐Ÿ‡ง UK
Novavax
NVAX
โ‚ฌ1.39 B 5,139.70%๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
โ‚ฌ2.18 B 8,081.86%๐Ÿ‡บ๐Ÿ‡ธ USA